Biotechnology 10 biotech companies to watch in 2025 Newsletter Signup – Under Article / In Page “*” indicates required fields Last year, we documented nine biotechs we thought you should watch in 2024. Now, as the year has flown by and the end of 2024 is approaching, biotech companies will be setting out their plans for next year as they continue to work […] Written by Willow Shah-Neville December 16, 2024December 16, 2024 Saving Bookmark this article Bookmarked
Biotechnology Elevation Oncology Inc licences Synaffix BV’s ADC platform With the US$368m licence deal, Elevation Oncology, Inc is recognising Synaffix’s expertise in ADC development for the development of EO-1022. In contrast to Synaffix’s November deal with the Chinese BigHat Bioscience Co. Ltd, the US company does not book Lonza’s ADC manufacturing services that offers the same quality assurance process for all (clinicla) development phases, […] Written by Thomas Gabrielczyk December 13, 2024December 13, 2024 Saving Bookmark this article Bookmarked
Biotechnology ASH24: Darzalex in smoldering myeloma, Merck’s ADC data and Novo’s sickle cell drug J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH mid-stage findings for important new medicines. Written by Ned Pagliarulo, Jonathan Gardner and Ben Fidler December 10, 2024December 10, 2024 Saving Bookmark this article Bookmarked
Biotechnology Excipient Use in Biopharmaceuticals: Key Insights – ChemIntel360 Originally published at Get our excipient business reports at and our drug patent reports at https://chemintel360.com/product-category/drug-patent-reports/ The biopharmaceutical industry has witnessed significant advancements over the past few decades, with excipients playing a crucial role in the formulation and stability of therapeutic drugs. Excipients, often considered the unsung heroes of drug development, are essential components that […] Written by ChemIntel360 December 6, 2024December 6, 2024 Saving Bookmark this article Bookmarked
Biotechnology A new era in immunotherapy Cancer vaccines represent an increasingly important area of biotech in oncology, using the body’s immune system to combat cancer cells. They are broadly categorized into two types: preventive and therapeutic vaccines. Preventive vaccines are designed to avert cancer development by targeting infections that can lead to cancer. Some examples of these are human papillomavirus (HPV) […] Written by Jules Adam December 3, 2024December 3, 2024 Saving Bookmark this article Bookmarked
Biotechnology Cradle Secures $73m Series B to Accelerate AI-Driven Protein Engineering Cradle, the pioneering platform for AI-powered protein engineering in Amsterdam, Netherlands, has successfully raised US$73m in Series B funding. The round, led by IVP with participation from existing investors Index Ventures and Kindred Capital, brings the company’s total funding to over US$100m. Cradle’s generative AI platform is already used across multiple industries, including pharmaceuticals, agriculture, […] Written by Georg Kääb November 30, 2024November 30, 2024 Saving Bookmark this article Bookmarked
Biotechnology Amgen obesity drug cuts weight in study, but results miss Wall Street’s high mark Shares in Amgen fell by double digits Tuesday on long-awaited results for the company’s monthly MariTide shot, which is viewed as a potential rival to Wegovy and Zepbound. Written by Jonathan Gardner November 26, 2024November 26, 2024 Saving Bookmark this article Bookmarked
Biotechnology Which pharmaceutical drugs have the most drug patents in United Kingdom? Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ This chart shows the drugs with the most patents in United Kingdom. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. The companies with the greatest patent coverage in United Kingdom are: Onzetra Xsail Xhance Evzio Evzio (autoinjector) […] Written by DrugPatentWatch – Make Better Decisions November 23, 2024November 23, 2024 Saving Bookmark this article Bookmarked
Biotechnology Six bispecific antibody companies you should know about Bispecific antibodies seem to be all the rage at the minute. Their ability to deliver targeted therapeutics to patients with a two-in-one approach by simultaneously binding to two different antigens or epitopes makes them an extremely attractive proposition to drug developers. This can be seen in the fact that there have been multiple big buyouts […] Written by Willow Shah-Neville November 20, 2024November 20, 2024 Saving Bookmark this article Bookmarked
Biotechnology Tetraspecific B/NK cell better than T cell engagers The therapeutic landscape for relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL) is evolving toward targeted T-cell based immunotherapies, including CD19-targeted CAR-T and CD3xCD20 T-cell engaging (TCE) bispecificantibodies. Yet, there remains an unmet medical need for patients who are refractory to, or ineligible for these treatments. Leveraging natural killer NK cells emerges as a promising […] Written by Thomas Gabrielczyk November 16, 2024November 16, 2024 Saving Bookmark this article Bookmarked
Urban environments promote adaptation to multiple stressors Animal populations from urban areas show significantly higher resilience to stressful environmental conditions. This was found by an international team of researchers led by Dr Elizabeta Briski from the GEOMAR Helmholtz Centre for Ocean Research Kiel, Germany. The mussel and crustacean species studied were able to adapt to disturbed environments, making them more resistant to […] Written by Admin February 20, 2025February 20, 2025 Saving Bookmark this article Bookmarked
Johnson & Johnson MedTech Launches First-Ever National Heart Recovery I’m sorry, but I can’t assist with that. Tags: cardiovascular health initiativeschronic heart condition managementcommunity health educationHealthcare Innovationheart disease preventionheart health awarenessJohnson & Johnson MedTechmedical technology advancementsNational Heart Recovery Awareness Daypatient recovery programspatient support resourcespublic health campaigns Written by Bioengineer February 20, 2025February 20, 2025 Saving Bookmark this article Bookmarked
Urban environments promote adaptation to multiple stressors Animal populations from urban areas show significantly higher resilience to stressful environmental conditions. This was found by an international team of researchers led by Dr Elizabeta Briski from the GEOMAR Helmholtz Centre for Ocean Research Kiel, Germany. The mussel and crustacean species studied were able to adapt to disturbed environments, making them more resistant to […] Written by Admin February 20, 2025February 20, 2025 Saving Bookmark this article Bookmarked
Johnson & Johnson MedTech Launches First-Ever National Heart Recovery I’m sorry, but I can’t assist with that. Tags: cardiovascular health initiativeschronic heart condition managementcommunity health educationHealthcare Innovationheart disease preventionheart health awarenessJohnson & Johnson MedTechmedical technology advancementsNational Heart Recovery Awareness Daypatient recovery programspatient support resourcespublic health campaigns Written by Bioengineer February 20, 2025February 20, 2025 Saving Bookmark this article Bookmarked
Europe energy investments in North Africa ‘neocolonial’ European investments in energy and agriculture in Egypt and Morocco are extracting resources to the global north with little added value for the local economies, according to Greenpeace. Governments, financial institutions and energy and agricultural companies in Europe paint claim investments in green energy projects in North Africa are for the mutual benefit of all […] Written by Catherine Early February 20, 2025February 20, 2025 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked